Multiple Sclerosis
Conditions
Keywords
Mindfulness
Brief summary
This project aims to implement and investigate a mindfulness-based stress reduction (MBSR) in people with multiple sclerosis (PwMS). The main objective is to implement MBSR intervention for PwMS in a major tertiary care clinic for PwMS. We will iteratively refine the intervention as required based on stakeholder feedback and any other emergent contextual findings. Participants will be asked to take part in an 8-week MBSR course and report changes in anxiety, depression, quality of life, emotional regulation, self-compassion, mindfulness, and health services use.
Interventions
BEHAVIORALMindfulness-Based Stress Reduction
Eight iterations of the MBSR course will be delivered, over a total period of 24 months. Each iteration will take place over 8 weeks. Courses would consist of 8 weekly sessions, led by certified mindfulness instructors. Sessions will include core meditation practices, psychoeducation, and home practices.
Sponsors
Robert Simpson
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
1. Age \>18 years \</= 60 years 2. Diagnosis of MS or related condition (Clinically Isolated Syndrome, Neuromyelitis Optica Spectrum Disorder, Chronic Inflammatory Demyelinating Neuropathy) 3. Able to understand spoken and written English 4. Willing to take part in an MBSR course
Exclusion criteria
1. Cognitive impairment (\<26 on the Montreal Cognitive Assessment) 2. Severe active mental health impairment (psychosis, suicidality) 3. Medical instability (terminal/life threatening inter-current illness)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Recruitment | 24 months | The investigators will measure the number of participants eligible for and recruited to the study. |
| Retention | 24 months | The investigators will measure the percentage of participants who complete outcome data. |
| Adherence | 24 months | The investigators will measure the number of participants who completed the mindfulness-based stress reduction course. |
| Follow-up rates | 24 months | The investigators will measure the percentage of participants who complete outcome measures pre-intervention, post-intervention, and at 3 months post-intervention. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Health services use | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Client Services Receipt Inventory. This instrument is used to collect information on the use of health services. |
| Emotion regulation | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Difficulties in Emotion Regulation Scale - Short Form. Answers are assessed using a 5-point Likert scale. Higher values indicate greater difficulties in emotion regulation. |
| Self-compassion | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Self-Compassion Scale - Short Form. The total score ranges from a 1-5 Likert scale, with higher scores representing high self-compassion. |
| Mindfulness | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Five-facet Mindfulness Questionnaire. Answers are assessed using a 5-point Likert scale. Higher scores in each facet indicate higher levels of mindfulness. |
| Climate | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Group Climate Questionnaire-Engage Scale. Each item response is measured on a Likert scale from 0-6, with total subscale scores reflecting the average of responses. Higher scores indicate higher group engagement. |
| Quality of Life using the Multiple Sclerosis Impact Scale (MSIS-29) | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Multiple Sclerosis Impact Scale. Items on the scale have a Likert scale from 1-5, with a range of 0-100 total and higher scores indicating greater disability. |
| Sleep | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Insomnia Severity Index. The total score ranges from 0-28, with higher scores indicating worse insomnia. |
| Pain Effects | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Pain Effects Scale. The total score ranges from 6-30, with higher scores indicating greater impact of pain on behavior and mood. |
| Fatigue | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Modified Fatigue Impact Scale. The total score ranges from 0-84, with higher scores indicating a greater impact of fatigue. |
| Cognitive function | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Symbol Digits Modalities Test. The total score ranges from 0-110, with higher scores indicating better cognitive functioning. |
| Therapeutic alliance | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Working Alliance Inventory. Each item is measured on a 7-point Likert scale, with a range of 36-252 total. Higher scores indicates stronger alliance. |
| Quality of Life using the EuroQol (EQ-5D-5L) | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the EQ-5D-5L. The total score ranges from 1-100, with higher values indicating better perceived health. |
| Anxiety | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Hospital Anxiety and Depression Scale. The total score ranges from 0-21, with higher values representing increased anxiety symptoms. |
| Depression | Measured at baseline, 8-week follow-up, and 3-month follow-up | Measured using the Hospital Anxiety and Depression Scale. The total score ranges from 0-21, with higher values representing increased anxiety symptoms. |
Countries
Canada
Contacts
Primary ContactRobert Simpson
Outcome results
None listed